StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
MCFL.BO$202.00-2.67%
Fair $202.00+0.0%

MCFL.BO

Mayank Cattle Food Limited

Consumer Defensive / Farm ProductsBSE

$202.00

-5.55 (-2.67%)

Fairly Valued+0.0%Fair Value $202.00Fund rank 22/100 · Data gapFallback financials|
SA 43/C
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $-49.3M · quality 35.7/100

Data gap 22/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 8/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

43/100

C

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · MCFL.BOLocal privado en este navegador · Mayank Cattle Food Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.1B

P/E

19.8x

↑

EV/EBITDA

10.8x

↑

ROE

15.7%

↑

Gross Margin

4.9%

↓

Debt/Equity

1.13

↑
52-Week Range$202
$144$241

TradingView lightweight chart

MCFL.BO price, volumen y niveles de valoración

Último $202.00Periodo +68.4%
Fair value: $202.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+6.7%

FCF CAGR

—

FCF margin

0.9%

FCF / Net income

0.68x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $3.91B · net income $50.4M · FCF $34.2M

2022-FY → 2025-FY

Gross margin

4.9%+2.1% pts

Operating margin

2.7%+1.7% pts

Net margin

1.3%+1.0% pts

FCF margin

0.9%+2.8% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$3.91B$3.91B$2.90B$3.09B$3.23B
Net Income$50.4M$50.4M$30.3M$12.7M$8.0M
EBITDA$133.6M$133.6M$96.4M$62.5M$45.5M
EPS9.339.337.802.361.48
Gross Margin4.9%4.9%5.0%3.8%2.9%
Operating Margin2.7%2.7%2.4%1.5%1.0%
Net Margin1.3%1.3%1.0%0.4%0.2%
Balance Sheet
Debt/Equity1.131.131.318.329.18
Current Ratio1.471.47———
Cash Flow
Free Cash Flow$34.2M$34.2M$-115.5M$-49.3M$-61.9M
Returns
ROE15.7%15.7%11.3%26.7%23.2%
Valuation
P/E19.8219.8214.48——
EV/EBITDA10.8110.818.20——
P/B3.403.401.63——
Growth & Yield
Revenue Growth34.8%34.8%-6.1%-4.2%—
EPS Growth19.6%19.6%231.0%59.2%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

24.3%

exigente

EPS terminal req.

$17.92

Spread vs growth

-4.7%

5Y implied EPS CAGR

18.4%

exigente

EPS terminal req.

$21.69

Spread vs growth

1.2%

10Y implied EPS CAGR

14.1%

razonable

EPS terminal req.

$34.93

Spread vs growth

5.5%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -13.9%

Total return

-13.9%

Start / end P/E

30.1x → 21.7x

EPS bridge

7.80 → 9.33

Residual

-5.5%

EPS growth+19.6%
Multiple rerating-28.0%
Dividend+0.0%
Residual / FX / buybacks / cross-term-5.5%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.